Novel compounds and compositions for targeting cancer stem cells

Details for Australian Patent Application No. 2011227022 (hide)

Owner Boston Biomedical, Inc.

Inventors Li, Chiang Jia; Leggett, David; Li, Youzhi; Li, Wei

Agent Cullens

Pub. Number AU-A-2011227022

PCT Pub. Number WO2011/116398

Priority 61/315,890 19.03.10 US; 61/325,814 19.04.10 US; 61/315,886 19.03.10 US

Filing date 21 March 2011

Wipo publication date 22 September 2011

International Classifications

A61K 31/27

Event Publications

27 September 2012 PCT application entered the National Phase

  PCT publication WO2011/116398 Priority application(s): WO2011/116398

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011227023-Novel methods for targeting cancer stem cells

2011227021-Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide